A.D.A.M. Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
A.D.A.M. General Information
Description
Developer of a point-of-care medical device production system designed for medical professionals to receive in-house printed, sterilized, personalized implants. The company's system combines proprietary three-dimensional printing technology, proprietary materials, and software to manufacture bioresorbable and biodegradable patient-specific implants, enabling medical professionals and the healthcare industry to reduce costs and save time in bone surgeries.
Contact Information
Website
www.adambioprinting.comCorporate Office
- Serendipity Labs, 700 Canal Street
- 1st floor
- Stamford, CT 06902
- United States
Corporate Office
- Serendipity Labs, 700 Canal Street
- 1st floor
- Stamford, CT 06902
- United States
A.D.A.M. Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 02-Nov-2023 | Completed | Out of Business | |||
| 7. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 6. Early Stage VC (Series A) | 18-Oct-2023 | Completed | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 19-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 10-May-2022 | Completed | Pre-Clinical Trials | |||
| 3. Equity Crowdfunding | 01-May-2022 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
A.D.A.M. Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
A.D.A.M. Comparisons
Industry
Financing
Details
A.D.A.M. Competitors (3)
One of A.D.A.M.’s 3 competitors is Limacorporate, a Formerly PE-Backed company based in Udine, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Limacorporate | Formerly PE-Backed | Udine, Italy | ||||
| Formlabs | Venture Capital-Backed | Somerville, MA | ||||
| Lithoz | Formerly VC-backed | Vienna, Austria |
A.D.A.M. Patents
A.D.A.M. Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024229333-A1 | Bioprinting workflows for healthcare professionals | Inactive | 03-May-2023 | ||
| EP-4247621-A2 | A novel three-dimensional ceramic printer having a printing powder compression system | Inactive | 19-Nov-2020 | ||
| EP-4247621-A4 | A novel three-dimensional ceramic printer having a printing powder compression system | Inactive | 19-Nov-2020 | ||
| US-20240075651-A1 | A novel three-dimensional ceramic printer having a printing powder compression system | Inactive | 19-Nov-2020 | ||
| WO-2022108826-A2 | A novel three-dimensional ceramic printer having a printing powder compression system | Inactive | 19-Nov-2020 | B33Y10/00 |
A.D.A.M. Signals
A.D.A.M. FAQs
-
When was A.D.A.M. founded?
A.D.A.M. was founded in 2019.
-
Where is A.D.A.M. headquartered?
A.D.A.M. is headquartered in Stamford, CT.
-
What is the size of A.D.A.M.?
A.D.A.M. has 14 total employees.
-
What industry is A.D.A.M. in?
A.D.A.M.’s primary industry is Therapeutic Devices.
-
Is A.D.A.M. a private or public company?
A.D.A.M. is a Private company.
-
What is A.D.A.M.’s current revenue?
The current revenue for A.D.A.M. is .
-
How much funding has A.D.A.M. raised over time?
A.D.A.M. has raised $1.16M.
-
Who are A.D.A.M.’s competitors?
Limacorporate, Formlabs, and Lithoz are competitors of A.D.A.M..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process